The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ®) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection
已获批准的减毒活基孔肯雅病毒疫苗 (IXCHIQ®) 可引发交叉中和抗体广度，扩展到多种致关节炎性甲病毒，类似于自然感染后的抗体广度
期刊:Vaccines
影响因子:
doi:10.3390/vaccines12080893
Whitney C Weber, Zachary J Streblow, Craig N Kreklywich, Michael Denton, Gauthami Sulgey, Magdalene M Streblow, Dorca Marcano, Paola N Flores, Rachel M Rodriguez-Santiago, Luisa I Alvarado, Vanessa Rivera-Amill, William B Messer, Romana Hochreiter, Karin Kosulin, Katrin Dubischar, Vera Buerger, Dani
